Australia markets close in 42 minutes

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.52-0.24 (-3.09%)
At close: 04:00PM EST
7.50 -0.02 (-0.27%)
After hours: 04:38PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts6266
Avg. Estimate-0.92-0.97-3.89-3.86
Low estimate-0.95-1.01-3.93-4.71
High estimate-0.86-0.93-3.84-2.23
Year ago EPS-0.31-1.04-0.93-3.89
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts6166
Avg. EstimateN/AN/A10kN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/A10kN/A
Year ago sales40kN/A168k10k
Sales growth (year/est)N/AN/A-94.00%N/A
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS-0.86-0.87-1.03-1.07
Actual EPS-0.31-1.04-1.04-0.9
Difference0.55-0.17-0.010.17
Surprise %64.00%-19.50%-1.00%15.90%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.92-0.97-3.89-3.86
7 days ago-0.92-0.97-3.89-3.86
30 days ago-1.11-1.05-4.26-4.42
60 days ago-1.11-1.05-4.26-4.42
90 days ago-1.11-1.05-4.26-4.42
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days6165
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLUMOIndustrySector(s)S&P 500
Current qtr.-196.80%N/AN/AN/A
Next qtr.6.70%N/AN/AN/A
Current year-318.30%N/AN/AN/A
Next year0.80%N/AN/AN/A
Next 5 years (per annum)15.20%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A